kre-celazine
MEDIA
November 9, 2014
A Single-Center, Double-Blind Placebo Controlled Study to Evaluate the Efficacy of Kre-Celazine®, an Oral Buffered Creatine-Cetylated Fatty Acid Compound, in its Ability to Reduce Site-specific Inflammation […]
June 9, 2014
Kre-Celazine® as a Viable Treatment for Juvenile Rheumatoid/Idiopathic Arthritis: A Pilot Study Jeff Golini, Wendy Jones, MS All American Pharmaceutical, Billings, MT and Royal Knight, Incorporated, […]
April 9, 2014
Buffered Vs Non-Buffered Aliphatic Fatty Acids and their Anti-Proliferative Effects in Human Tumor Cell Lines Jeff Golini, Wendy Jones, MS All American Pharmaceutical, Billings, MT and […]